Charles Pollack MD (@md_pollack) profile picture

Medical Education & Research Tweets my own; RTs are not endorsements

Joined March 2020
Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)Photo by Charles Pollack MD (@md_pollack)
Charles Pollack MD retweeted
3/8: A hierarchical #WinRatio was calculated for each plaque-based care patient vs each usual care patient for 4 outcomes, ranked by clinical priority:
1
7
13
1,876
After analyzing 2,500 angios over 2 years, I'm done. Nights, weekends—all consumed. I'm tired. My rods & cones would like a word: They miss color. I’m trading cath lab grayscale for summer’s full palette. They miss joy. They miss art. I want summer & paint in my eyes—not contrast and cine runs. Time to swap arteries for art. 🎨☀️ #cmgsays #cmgsees color in his future
25
15
5
184
13,444
Charles Pollack MD retweeted
🆕🆓 #CME from @academiccme: Update on Best Practices for the Prompt and Personalized Management of Patients with #COPD Exacerbations, by William Corrao @BrighamWomens! Click on academiccme.com/courses/upda…. Salute to @GOLD_COPD! Originally presented at @EPulmonaryConf 2022.
3
6
Charles Pollack MD retweeted
Great to be involved in #CardioSteps with my friend @amrelhadidyy - unfortunately this year for me will be virtual. @Hragy @aymanka @MohanedEgred @Sarah_Moharem @BassemZarif @DrAmirKaki
2
11
1
55
Read the 12 key points to remember about this scientific statement from the AHA for the management of patients at risk for and with left ventricular thrombus: https://nitter.cf/t.co/CxoGBhuYNU #cvACS
1
33
2
73
Excited to be attending the 2022 Vulnerable Plaque, Vulnerable Patient Meeting, joining a terrific group of faculty to speak on advanced #plaque analysis using #yesCCT. Virtual attendance is an option 👉 https://nitter.cf/t.co/VnSjlseynR
1
8
1
22
Charles Pollack MD retweeted
20) Mark your best response and RETURN TOMORROW for the correct answer and more #ERA22 data on #SGLT2i and #DKD, along with a link to your 🆓CE/#CME. 👏@ClaraGCarro @PepaSolerR @SENefrologia @JonathanNefro @nefrocat @jlgorriz @EdoardoMelilli @SVNefro @CKJsocial @torra_roser
2
9
12
Charles Pollack MD retweeted
16) In addition, in the new revision of guidelines, level of #GFR has been lowered to 20 ml/min according to #EMPEROR, #DAPA_CKD, & #CREDENCE trials for the use of #SGLT2i.
1
2
9
Charles Pollack MD retweeted
15) In European guidelines @goKDIGO, the use of SGLT2i is already first-line drug therapy in #T2D.
1
3
8
Charles Pollack MD retweeted
14) Taking all of this together, the renal benefits to patients with #T2D of the use of SGLT2i are obvious. Thus, @goKDIGO, @AmDiabetesAssn and @escardio @escardionews guidelines recommend its use as follows, as per a talk at #ERA22 conducted by Dr. Paola Fioretto.
1
3
13
Charles Pollack MD retweeted
4) So let's start with a quick knowledge ✔️. What is the recommended first line drug therapy for #diabetes_mellitus and chronic kidney disease (#CKD)? a. #Metformin b. Metformin + #RAASB c. Metformin + #SGLT2i d. Metformin + SGLT2i + RAASB
3%a
9%b
26%c
63%d
155 votes • Final results
1
2
2
7
Charles Pollack MD retweeted
2) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. It was held in May. Our expert author is Dr. Sheila Bermejo (@shbermejo) from @vallhebron in Barcelona, Spain.
1
4
1
8
Charles Pollack MD retweeted
18) Whew! After years of stagnation, we are starting to understand better. Think on how these new concepts may impact on other glomerular disorders --and return tomorrow for more a focused view on proteinuria in IgAN & your link to 🆓CE/#CME!
1
3
8
Charles Pollack MD retweeted
15b) 👉Drugs that ↓ glom. hyperfiltration (#RAASi, #SGLT2i, upcoming: Sparsentan) 👉Drugs that ↓ #GFR decline (RAASi/SGLT2i, maybe #MRA?)
1
1
6
Charles Pollack MD retweeted
15a) But how to address proteinuria in FSGS, if not with steroids, et al? 👉Eliminate #podocyte toxins, infections, or any other causative agents 👉Control risk factors for glom. hyperfiltration (DM, obesity, high salt intake) (cont)
1
1
5
Charles Pollack MD retweeted
4b) What are possible causes of the proteinuria? A.Glomerular proteinuria B.Tubular proteinuria C.Overflow proteinuria D.Physiological proteinuria
55%A
3%B
19%C
22%D
134 votes • Final results
1
2
1
5
#PCSK9i #Safety stay tuned for the results of the Open Label Extension (OLE) FOURIER which will be presented at #ESCcongress
2
16
60
Once a patient in the state’s only children’s hospital, @childrensofms, Abby McCardle is now a nurse there, giving her insight into care and a special relationship with colleagues who were once her nurses. Read the story: https://nitter.cf/t.co/evZo6QG1fC
1
3
1
16
Charles Pollack MD retweeted
16) Before we conclude, let’s review how pharmacists can optimize the care of patients with #cardiometabolic risk: •Reduce medication errors •Improve #CV risk-factor control •Enhance #knowledge, #adherence and #QoL
1
2
3